Kgaladi, J.; Faber, M.; Dietzschold, B.; Nel, L.H.; Markotter, W.
Pathogenicity and Immunogenicity of Recombinant Rabies Viruses Expressing the Lagos Bat Virus Matrix and Glycoprotein: Perspectives for a Pan-Lyssavirus Vaccine. Trop. Med. Infect. Dis. 2017, 2, 37.
https://doi.org/10.3390/tropicalmed2030037
AMA Style
Kgaladi J, Faber M, Dietzschold B, Nel LH, Markotter W.
Pathogenicity and Immunogenicity of Recombinant Rabies Viruses Expressing the Lagos Bat Virus Matrix and Glycoprotein: Perspectives for a Pan-Lyssavirus Vaccine. Tropical Medicine and Infectious Disease. 2017; 2(3):37.
https://doi.org/10.3390/tropicalmed2030037
Chicago/Turabian Style
Kgaladi, Joe, Milosz Faber, Bernhard Dietzschold, Louis H. Nel, and Wanda Markotter.
2017. "Pathogenicity and Immunogenicity of Recombinant Rabies Viruses Expressing the Lagos Bat Virus Matrix and Glycoprotein: Perspectives for a Pan-Lyssavirus Vaccine" Tropical Medicine and Infectious Disease 2, no. 3: 37.
https://doi.org/10.3390/tropicalmed2030037
APA Style
Kgaladi, J., Faber, M., Dietzschold, B., Nel, L. H., & Markotter, W.
(2017). Pathogenicity and Immunogenicity of Recombinant Rabies Viruses Expressing the Lagos Bat Virus Matrix and Glycoprotein: Perspectives for a Pan-Lyssavirus Vaccine. Tropical Medicine and Infectious Disease, 2(3), 37.
https://doi.org/10.3390/tropicalmed2030037